Clinical Study

Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients

Figure 3

After treatment, mean dBMA Tregs in the whole (black), responder (green), and nonresponder (red) patient groups, respectively (22 versus 12/μL, paired -test, , 28 versus 7/μL, Wilcoxon signed-rank test ; 18 versus 14/μL, paired -test, ).